| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 188 | 2022 |
| Exome-wide association study on alanine aminotransferase identifies sequence variants in the GPAM and APOE associated with fatty liver disease O Jamialahmadi, RM Mancina, E Ciociola, F Tavaglione, PK Luukkonen, ... Gastroenterology 160 (5), 1634-1646. e7, 2021 | 107 | 2021 |
| A polygenic risk score to refine risk stratification and prediction for severe liver disease by clinical fibrosis scores A De Vincentis, F Tavaglione, O Jamialahmadi, A Picardi, RA Incalzi, ... Clinical Gastroenterology and Hepatology 20 (3), 658-673, 2022 | 84 | 2022 |
| Rare ATG7 genetic variants predispose patients to severe fatty liver disease GA Baselli, O Jamialahmadi, S Pelusi, E Ciociola, F Malvestiti, M Saracino, ... Journal of Hepatology 77 (3), 596-606, 2022 | 50 | 2022 |
| Development and validation of a score for fibrotic nonalcoholic steatohepatitis F Tavaglione, O Jamialahmadi, A De Vincentis, S Qadri, ME Mowlaei, ... Clinical Gastroenterology and Hepatology 21 (6), 1523-1532. e1, 2023 | 49 | 2023 |
| Impact of risk factors for gestational diabetes (GDM) on pregnancy outcomes in women with GDM T Filardi, F Tavaglione, M Di Stasio, V Fazio, A Lenzi, S Morano Journal of Endocrinological Investigation 41, 671-676, 2018 | 44 | 2018 |
| Endocrine aspects of metabolic dysfunction associated steatotic liver disease (MASLD): Beyond insulin resistance AL Hutchison, F Tavaglione, S Romeo, M Charlton Journal of Hepatology, 2023 | 36 | 2023 |
| Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women A Cherubini, M Ostadreza, O Jamialahmadi, S Pelusi, E Rrapaj, E Casirati, ... Nature Medicine 29 (10), 2643-2655, 2023 | 30 | 2023 |
| PSD3 downregulation confers protection against fatty liver disease RM Mancina, K Sasidharan, A Lindblom, Y Wei, E Ciociola, ... Nature metabolism 4 (1), 60-75, 2022 | 27 | 2022 |
| High serum osteopontin levels are associated with prevalent fractures and worse lipid profile in post-menopausal women with type 2 diabetes T Filardi, V Carnevale, R Massoud, C Russo, L Nieddu, F Tavaglione, ... Journal of Endocrinological Investigation 42, 295-301, 2019 | 22 | 2019 |
| Genetic risk scores and personalization of care in fatty liver disease C Bianco, F Tavaglione, S Romeo, L Valenti Current Opinion in Pharmacology 61, 6-11, 2021 | 21 | 2021 |
| Effect of common genetic variants on the risk of cirrhosis in non‐alcoholic fatty liver disease during 20 years of follow‐up M Holmer, M Ekstedt, P Nasr, R Zenlander, A Wester, F Tavaglione, ... Liver International 42 (12), 2769-2780, 2022 | 19 | 2022 |
| Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery F Tavaglione, A De Vincentis, V Bruni, IF Gallo, S Carotti, D Tuccinardi, ... Liver International 42 (2), 374-383, 2022 | 19 | 2022 |
| Human and molecular genetics shed lights on fatty liver disease and diabetes conundrum F Tavaglione, G Targher, L Valenti, S Romeo Endocrinology, Diabetes & Metabolism 3 (4), e00179, 2020 | 18 | 2020 |
| Inborn and acquired risk factors for severe liver disease in Europeans with type 2 diabetes from the UK Biobank F Tavaglione, A De Vincentis, O Jamialahmadi, R Pujia, R Spagnuolo, ... JHEP Reports 3 (3), 100262, 2021 | 17 | 2021 |
| Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank A De Vincentis, F Tavaglione, R Spagnuolo, R Pujia, D Tuccinardi, ... International Journal of Obesity 46 (3), 486-493, 2022 | 14 | 2022 |
| Fatty liver disease, heart rate and cardiac remodelling: Evidence from the UK Biobank O Jamialahmadi, F Tavaglione, A Rawshani, C Ljungman, S Romeo Liver International 43 (6), 1247-1255, 2023 | 10 | 2023 |
| Genetic variants in the MTHFR are not associated with fatty liver disease A De Vincentis, RM Mancina, J Pihlajamäki, V Männistö, S Petta, ... Liver International 40 (8), 1934-1940, 2020 | 10 | 2020 |
| A genetic and metabolic staging system for predicting the outcome of nonalcoholic fatty liver disease G Pennisi, RM Pipitone, M Enea, A De Vincentis, S Battaglia, V Di Marco, ... Hepatology Communications 6 (5), 1032-1044, 2022 | 9 | 2022 |
| The SNP rs9677 of VPAC1 gene is associated with glycolipid control and heart function in female patients with type 2 diabetes: A follow-up study F Tavaglione, T Filardi, M Fallarino, E Mandosi, I Turinese, M Rossetti, ... Nutrition, Metabolism and Cardiovascular Diseases 26 (2), 109-113, 2016 | 7 | 2016 |
